AI Articles and Analysis about Predictive analytics and forecasting

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

AI and data science have seen increased use in life sciences, particularly in the pharmaceutical industry. However, despite the multitude of AI use cases, pharmaceutical companies tend not to embrace every emerging AI trend eagerly. 

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Companies that use AI copilots experience numerous benefits, including streamlined processes, improved customer experience, and cost savings. Large language models (LLMs) form the basis of many AI copilot applications. While LLMs have a remarkable capacity to generate humanlike text, that same capability is the reason businesses need to exercise caution in order to prevent misapplications of this otherwise transformative technology. 

IQVIA is a Fortune 500 health information technology (HIT) and clinical research company that provides advanced analytics, technology solutions, and clinical research services for various healthcare stakeholders. 

This interview analysis is sponsored by Riskified and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Takeda Pharmaceuticals is a 240-year-old, leading biopharmaceutical company headquartered in Tokyo, Japan, with a global hub in Cambridge, Massachusetts. The company has a global presence, operating in more than 80 countries across North America, Europe and Asia.

This interview analysis is sponsored by Uniphore and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.